Patients with increased FCN2 in the rapid response phase had higher muscle pain, which reveals a link between the immune overactivation in ME/CFS patients and the pain they are experiencing. The gene discussed is FCN2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.